Introduction to the Founding and History of Anthroposophic Medicine 

Peter Heusser

Last update: 15.10.2020

The beginning Anthroposophic Medicine can be traced back to 1920 (1, pp. 306–307), when Rudolf Steiner (1861–1925) began giving lecture cycles for professionals on the topic of spiritual-scientific aspects in medicine, at the request of interested pharmacists and physicians (2). These lectures continued until 1924. They were usually stenographed and are still available in book form in the Rudolf Steiner Complete Edition. Clinical-therapeutic institutes were first established in Arlesheim (near Basel, Switzerland) and Stuttgart (Germany) in 1921 (3), and in direct connection with this, laboratories for the production of medicines were built, from which the company Weleda emerged (4). At the turn of the year 1923/24, a Medical Section was established within the framework of the then newly founded School of Spiritual Science at the Goetheanum in Dornach (Switzerland). Its leader was the Dutch physician Ita Wegman (1876–1943), who had trained in Switzerland and was the founder of the first Clinical Therapeutic Institute in Arlesheim. Together with Wegman, Steiner wrote the first book on Anthroposophic Medicine, published in 1925: “Extending practical medicine. Fundamental principles based on the science of the spirit” (5).
In this publication, as well as many times in medical lectures and in other contexts, Steiner clearly pointed out that Anthroposophic Medicine does not stand in opposition to regular scientific medicine; it is fully based on it and attempts to expand scientific knowledge through spiritual-scientific insights.

We see an expansion of knowledge of the world and humanity in anthroposophy, founded by Rudolf Steiner. To the knowledge of the physical human being, which can only be gained through the scientific methods of the present, anthroposophy adds that of the spiritual human being. It does not pass from knowledge of the physical to knowledge of the spiritual by mere reflection. If it did so one would be confronted only with more or less well thought-out hypotheses, which nobody can prove to have any correspondence with reality.
Before making statements about the spiritual, anthroposophy develops the methods that entitle it to make such statements.

Bibliography

  1. Heusser P. Anthroposophie und Wissenschaft. Eine Einführung. Dornach: Verlag am Goetheanum; 2016. English translation: Heusser P. Anthroposophy and science. An introduction. Frankfurt am Main: Peter Lang; 2016, p. 271–272.
  2. Steiner R. Geisteswissenschaft und Medizin. GA 312. 8th ed. Basel: Rudolf Steiner Verlag; 2020. English translation: Steiner R. Introducing anthroposophical medicine. Great Barrington: Steiner Books; 2011.
  3. van Deventer M. Die anthroposophisch-medizinische Bewegung in den verschiedenen Etappen ihrer Entwicklung. Arlesheim: Natura Verlag; 1992.
  4. Kugler W (ed.). Rudolf Steiner und die Gründung der Weleda. Beiträge zur Rudolf Steiner Gesamtausgabe no. 118/119. Dornach: Rudolf Steiner Nachlassverwaltung; 1997.
  5. Steiner R, Wegman I. Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenschaftlichen Erkenntnissen. GA 27. 8th ed. Basel: Rudolf Steiner Verlag; 2014. English translation: Steiner R, Wegman I. Extending practical medicine. Fundamental principles based on the science of the spirit. London: Rudolf Steiner Press; 2000.

Research news

Case series: Topical application of Viscum album extract in keratinocyte carcinomas shows remissions 
A retrospective case series examined the safety and clinical effects of topical application of 10% lipophilic Viscum album extract (VALE) in individual cases of cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC) and actinic keratosis (AK). The study population consisted of 55 patients with 74 skin lesions. Risk factors, concomitant therapies and diseases, adverse drug reactions to VALE and other relevant information were documented. As a result, the clinical response rate was 78% for cSCC, 70% for BCC and 71% for AK. The complete remission rates for individual lesions were 56% for cSCC, 35% for BCC and 15% for AK. Overall, the results suggest that VALE is a safe and tolerable extract, and complete and partial remissions of ceratinocyte carcinomas were observed with its use. The article is published in Complementary Medicine Research
https://doi.org/10.1159/000537979.


Further information on Anthroposophic Medicine